A Phase 1a/1b Dose Escalation/Expansion Study of the Anti-PD-1 Monoclonal Antibody Nofazinlimab in Chinese Patients with Solid Tumors or Lymphoma.

Jifang GongYe GuoYanqiao ZhangYi BaTong ChenWei LiCaicun ZhouMengzhao WangHaiyan YangYuhong ZhouQiqing CaiZiping WangGang HuangWei ZhangRila SuZhongheng CaiZenglian YueJinzhou DouPeiqi LiRachel WuArchie N TseLin Shen

Published in: Targeted oncology (2024)

NCT03809767; registered 18 January 2019.

Keyphrases

monoclonal antibody
diffuse large b cell lymphoma
open label
randomized controlled trial
study protocol